6. SURGICAL TREATMENT OUTCOMES FOR MULTIDRUG-RESISTANT COMPLEX SOFT TISSUE INFECTIONS
Main Article Content
Abstract
Introduction: Multidrug-resistant infections are an increasingly serious global healthcare issue, extending hospital stays and raising mortality rates. Complex soft tissue infections caused by multidrug-resistant organisms pose significant challenges for surgeons due to the limited antibiotic options available. Surgical debridement and, more recently, the advent of the Vacuum-Assisted Closure (VAC) system with irrigation have proven to be effective methods for treating complex infected wounds.
Subjects - Research Methods: This is a case series study describing complex soft tissue infections caused by multidrug-resistant organisms, treated with surgical debridement combined with multiple rounds of VAC with irrigation at the Department of Orthopedic Trauma, University Medical Center Ho Chi Minh City.
Results: From April 2024 to October 2024, we encountered 6 cases of complex soft tissue infections, all of which yielded cultures with multidrug-resistant organisms: Methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae ESBL (-), AmpC (-), Pseudomonas aeruginosa, AmpC (-); and Enterobacter aerogenes ESBL (-), AmpC (-). One case involved sepsis and multiple soft tissue infections caused by Burkholderia pseudomallei. Patients underwent an average of 3.16 debridement surgeries and 3 VAC cycles, with 100% of cultures returning negative results and infection markers returning to normal. Four out of six cases had their wounds completely closed upon discharge, one case continued VAC therapy at home before returning for skin grafting, and one case remains under outpatient wound care.
Conclusion: Surgical debridement combined with multiple rounds of VAC with irrigation proves to be an effective method for treating complex, multidrug-resistant soft tissue infections.
Article Details
Keywords
Complex soft tissue infections, multidrug-resistant, surgical debridement, VAC system with irrigation
References
[2] Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: No ESKAPE! An update from the infectious diseases society of America. J Antimicrob Chemother. 2021;76(Suppl 4).
[3] Choi J, Narayan RK. Management of skin and soft tissue infections. Infect Dis Clin North Am. 2020;34(4):787-809.
[4] Barbier F, Timsit JF. Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection. Curr Opin Infect Dis. 2020;33(2):137-145.
[5] European Wound Management Association (EWMA). Negative pressure wound therapy: Overview and principles. Cambridge Media; 2024.
[6] Nguyễn Chí Nguyện, Nguyễn Thành Tấn, Nguyễn Kim Ngân. Đánh giá kết quả hút áp lực âm trong điều trị vết thương phần mềm phức tạp tại Bệnh viện Trường Đại học Y Dược Cần Thơ năm 2019 - 2020. Tạp chí Y Dược học Cần Thơ. 2022;48:128-136.
[7] Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH. Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Infect Drug Resist. 2018;11:1959-1974.
[8] Elhessy AH, Chaudhry AR, Hammouda AI, Giacobbe SD, Gesheff MG, Conway JD. Experience with negative-pressure wound therapy with instillation in complex infected orthopaedic wounds. Int Wound J. 2021;18(6):902-908.
[9] Wolvos T. The evolution of negative pressure wound therapy: Negative pressure wound therapy with instillation. J Wound Care. 2015;24(4 Suppl):15-20.
[10] Jabbour JF, Sharara S, Kanj S. Treatment of multidrug-resistant Gram-negative skin and soft tissue infections. Curr Opin Infect Dis. 2020;33.